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CorrespondenceReplyTo the Editor:
In our recent report we studied associations between early-life
exposure to individual bacterial genera of the indoor microbiota
and the development of asthma.1 In a correspondence to this
report, Fu et al2 compliment our novel approach, but question
some of the statistical choices made and ask for a new sensitivity
analysis.
The vast richness of indoor dust microbiota highlights the need
for data reduction. Therefore, instead of testing all potential
genera against asthma, we used a 2-step approach. First, we
performed a principal coordinate analysis to summarize the
relative abundance weighted phylogenetic variance of all
bacterial data available and then identified those 2 axes that
were associated with asthma. In the second step, we identified
bacterial genera using correlation analyses with these 2 axes. In
this second step, we favored biological criterion over statistical
criteria, which can naturally be questioned. We used a fairly
relaxed criteria in the correlation analyses (r >j0.4j), but reduced
the data to avoid multiple testing by omitting microbes with low
population-level relative abundance, an approach that has been
used previously by others.3 This reduction is based on the
assumption that environmental microbes with low abundance
are biologically less likely to result in sufficient exposure to cause
health effects.
In response to the correspondence by Fu et al,2 we repeated the
principal coordinate analysis–based approach. The second step of
our analyses was performed without the mean relative
abundance–based restriction, that is, including all 658 genera
detected in the samples. In this sensitivity analysis, we identified
4 additional genera with mean abundance between 0.03 and 0.08
(Cellulomonas, Phycicoccus, unidentified genera within the C111
family (U.), and Cellvibrio) that were found to be inversely
associated (P < .1) with the development of asthma, but not
independently of each other.
In our original study, we also explored the possibility to create a
sum variable of the 12 protective bacterial genera that we
identified. Adding these 4 additional genera into the original
sum variable did not change the sum variable’s protective
association with asthma, but the new variable explained slightly
more of the association between bacterial richness and asthmathan the original sum variable (82% vs 77% [calculated with the
estimates from Table E4; explanation percentage (61%) that was
mentioned in the text was unfortunately incorrect], respectively).
Fu et al2 also request for the names of the original 12
genera. They are listed in Fig E3 in the article’s Online
Repository at www.jacionline.org,1 but we repeat them here:
Sphingomonas, Janthinobacterium, Brevibacterium, other genus
(O.) within the Dermabacteraceae family, Nocardioides,
Nocardioidaceae U., Microbacteriaceae U., Microbacteriaceae
O., Salinibacterium, Micrococcaceae U., Mycobacterium, and
Chitinophagaceae U.
We thank Fu et al2 for their insightful comments. We clearly
need larger studies and new methodological work, when the
aim is to identify individual, potentially very rare taxa that are
strongly associated with asthma. An alternative strategy is to
search for common characteristics across taxa. This strategy is
supported by our earlier4 and this current study, both of which
concluded that communities of selected bacteria are more
strongly linked to asthma protection than individual bacterial
taxa.
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